How
to Help Your Doctor – Easy Steps To Improve Your
Medical Care
MedicineNet, 2004
Adiyaman P., Ocal G., Berberoglu M., Evliyaoglu O., Aycan
Z., & Cetinkaya E. (2004). The
clinical and radiological assessment of cyclic
intravenous pamidronate administration in children with
osteogenesis imperfecta.
Turkish Journal of Pediatrics. 46(4):322-8.
[Clinical Trial. Journal Article]
Arikoski P. Silverwood B.
Tillmann V. Bishop N.J. (2004).
Intravenous
pamidronate treatment in children with moderate to severe
osteogenesis imperfecta: assessment of indices of
dual-energy X-ray absorptiometry and bone metabolic
markers during the first year of therapy.
Bone.
34(3):539-46. [Journal Article]
Bin-Abbas B.S., Al-Ashwal
A.A., Al-Zayed Z.S., & Sakati N.A. (2004).
Radiological
features of bisphosphonate therapy in children with
osteogenesis imperfecta.
Saudi Medical Journal. 25(11):1772-3. [Journal
Article]
Braga V. Gatti D. Rossini
M. Colapietro F. Battaglia E. Viapiana O. Adami S.
(2004). Bone
turnover markers in patients with osteogenesis
imperfecta. Bone.
34(6):1013-6. [Journal Article]
Cabral W.A. Marini J.C.
(2004). High
proportion of mutant osteoblasts is compatible with
normal skeletal function in mosaic carriers of
osteogenesis imperfecta.
American Journal of Human Genetics. 74(4):752-60.
[Journal Article]
Chamberlain J.R.,
Schwarze U., Wang P.R., Hirata R.K., Hankenson K.D. Pace
J.M., Underwood R.A., Song K.M., Sussman M., Byers P.H.
& Russell D.W. (2004). Gene
targeting in stem cells from individuals with
osteogenesis imperfecta.
Science. 303(5661):1198-201. [Journal
Article]
DiMeglio L.A., Ford L.,
McClintock C. & Peacock M. (2004).
Intravenous
pamidronate treatment of children under 36 months of age
with osteogenesis
imperfecta. Bone.
35(5):1038-45. [Clinical Trial. Journal
Article]
Engelbert R.H., Uiterwaal
C.S., Gerver W.J., van der Net J.J., Pruijs H.E. &
Helders P.J. (2004). Osteogenesis
imperfecta in childhood: impairment and disability. A
prospective study with 4-year follow-up.
Archives of
Physical Medicine & Rehabilitation. 85(5):772-8.
[Journal Article]
Ganesh A., Jenny C.,
Geyer J., Shouldice M. & Levin A.V.
(2004). Retinal
hemorrhages in type I osteogenesis imperfecta after minor
trauma. Ophthalmology.
111(7):1428-31. [Case Reports. Journal
Article]
Hartikka H., Kuurila K.,
Korkko J., Kaitila I., Grenman R., Pynnonen S., Hyland
J.C. & Ala-Kokko L. (2004).
Lack
of correlation between the type of COL1A1 or COL1A2
mutation and hearing loss in osteogenesis imperfecta
patients. Human
Mutation. 24(2):147-54. [Journal
Article]
Iwamoto J., Takeda T.
& Sato Y. (2004). Effect
of treatment with alendronate in osteogenesis imperfecta
type I: a case report. Keio
Journal of Medicine. 53(4):251-5. [Case Reports.
Journal Article]
Kaso G., Varju C. &
Doczi T. (2004). Multiple
vertebral fractures in osteogenesis imperfecta treated by
vertebroplasty. Case illustration.
Journal of
Neurosurgery Spine. 1(2):237.[Case Reports.
Journal Article]
Karabiyik L. & Capan
Z. (2004). Osteogenesis
imperfecta: different anaesthetic approaches to two
paediatric cases. Paediatric
Anaesthesia. 14(6):524-5. [Case Reports.
Letter]
Khan M.K. & Hossain
M.B. (2004). A
case of brittle bone disease.
Mymensingh Medical
Journal: MMJ. 13(2):199-200. [Case Reports.
Journal Article]
Kozloff K.M., Carden A.,
Bergwitz C., Forlino A., Uveges T.E., Morris M.D., Marini
J.C. & Goldstein S.A. (2004).
Brittle
IV mouse model for osteogenesis imperfecta IV
demonstrates postpubertal adaptations to improve whole
bone strength. Journal
of Bone & Mineral Research. 19(4):614-22.
[Journal Article]
Kuurila K. Grenman R.
(2004) Response
to 'Is it necessary to screen for hearing loss in the
pediatric population with osteogenesis
imperfecta?'.
Clinical Otolaryngology & Allied Sciences.
29(3):287. [Comment. Letter]
McLean K.R. (2004).
Osteogenesis
imperfecta.
Neonatal Network - Journal of Neonatal Nursing.
23(2):7-14. [Review]
Munns C.F., Rauch F.,
Zeitlin L., Fassier F. & Glorieux F.H. (2004).
Delayed
osteotomy but not fracture healing in pediatric
osteogenesis imperfecta patients receiving
pamidronate.
Journal of Bone & Mineral Research.
19(11):1779-86. [Journal Article]
Munns C.F., Rauch F.,
Ward L. & Glorieux F.H. (2004).
Maternal
and fetal outcome after long-term pamidronate treatment
before conception: a report of two
cases. Journal of
Bone & Mineral Research. 19(10):1742-5. [Case
Reports. Journal Article]
Niyibizi C., Wang S., Mi
Z. & Robbins P.D. (2004).
Gene
therapy approaches for osteogenesis
imperfecta. Gene
Therapy. 11(4):408-16. [Journal Article. Review.
Review, Tutorial]
Panzica M., Garapati R.,
Zelle B., Krettek C., Tscherne H. & Pape H.C. (2004).
Combination
of femoral fracture treatment and corrective osteotomy in
a child with osteogenesis imperfecta.
Archives of
Orthopaedic & Trauma Surgery. 124(5):341-5.
[Case Reports. Journal Article]
Popko J., Galicka A.,
Wolczynski S., Zalewski W., Konstantynowicz J. (2004).
[Polish] Osteogenesis
imperfecta as an interdisciplinary medical
problem. Chirurgia
Narzadow Ruchu i Ortopedia Polska. 69(4):235-9.
[Journal Article]
Prockop D.J. (2004).
Targeting
gene therapy for osteogenesis
imperfecta. New
England Journal of Medicine. 350(22):2302-4.
[Journal Article]
Ries-Levavi L.,
Ish-Shalom T., Frydman M., Lev D., Cohen S., Barkai G.,
Goldman B., Byers P. & Friedman E.
(2004). Genetic
and biochemical analyses of Israeli osteogenesis
imperfecta patients. Human
Mutation. 23(4):399-400. [Journal
Article]
Sakkers R., Kok D.,
Engelbert R., van Dongen A., Jansen M., Pruijs H.,
Verbout A., Schweitzer D. & Uiterwaal C. (2004).
Olpadronate
Reduced Fractures in Children with Osteogenesis
Imperfecta. Journal
of Bone & Joint Surgery - American Volume. 86A
(11):2575.
Sakkers R., Kok D.,
Engelbert R., van Dongen A., Jansen M., Pruijs H.,
Verbout A., Schweitzer D. & Uiterwaal C. (2004).
Skeletal
effects and functional outcome with olpadronate in
children with osteogenesis imperfecta: a 2-year
randomised placebo-controlled
study. Lancet.
363(9419):1427-31. [Clinical Trial. Journal
Article. Randomized Controlled Trial]
Saldanha K.A., Saleh M.,
Bell M.J. & Fernandes J.A. (2004).
Limb
lengthening and correction of deformity in the lower
limbs of children with osteogenesis imperfecta.
Journal of Bone
& Joint Surgery - British Volume. 86(2):259-65.
[Journal Article]
Schafer I.A., Stein J.,
Hyland J.C. & Clark B. (2004).
Gene
symbol: COL1A1. Disease: Osteogenesis imperfecta type I.
Human Genetics.
114(4):404. [Case Reports. Journal
Article]
Siegert T., Klein H.G.,
Marschall C. & Schmidt H. (2004). [German]
Osteogenesis
imperfecta Type 1: a case presentation with a new
mutation in gene COL1A1. Klinische
Padiatrie. 216(2):91-3. [Case Reports. Journal
Article]
Takahashi S., Okada K.,
Nagasawa H., Shimada Y., Sakamoto H. & Itoi E.
(2004). Osteosarcoma
occurring in osteogenesis imperfecta.
Virchows
Archiv. 444(5):454-8. [Case Reports. Journal
Article. Review. Review of Reported Cases]
Takken T., Terlingen H.C., Helders P.J., Pruijs H., Van
der Ent C.K. & Engelbert R.H. (2004).
Cardiopulmonary
fitness and muscle strength in patients with osteogenesis
imperfecta type I.
Journal of
Pediatrics. 145(6):813-8. [Journal
Article]
Tolboom N., Cats E.A.,
Helders P.J., Pruijs J.E. & Engelbert R.H. (2004).
Osteogenesis
imperfecta in childhood: effects of spondylodesis on
functional ability, ambulation and perceived competence.
European Spine
Journal. 13(2):108-13. [Journal
Article].
Zacharin M. &
Kanumakala S. (2004). Pamidronate
treatment of less severe forms of osteogenesis imperfecta
in children.
Journal of Pediatric Endocrinology. 17(11):1511-7.
[Clinical Trial. Journal Article]
